These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 18361887

  • 21. Enhanced acute responses in an experimental exposure model to biomass smoke inhalation in chronic obstructive pulmonary disease.
    Mattson JD, Haus BM, Desai B, Ott W, Basham B, Agrawal M, Ding W, Hildemann LM, Abitorabi KM, Canfield J, Mak G, Guvenc-Tuncturk S, Malefyt Rde W, McClanahan TK, Fick RB, Kuschner WG.
    Exp Lung Res; 2008 Dec; 34(10):631-62. PubMed ID: 19085563
    [Abstract] [Full Text] [Related]

  • 22. Medical and psychiatric illness: different but concurrent!
    Lenfant C.
    Metabolism; 2005 May; 54(5 Suppl 1):53-4. PubMed ID: 15877315
    [No Abstract] [Full Text] [Related]

  • 23. Cardiovascular risk assessment. Introduction.
    Foley KF.
    Clin Lab Sci; 2009 May; 22(4):223-5. PubMed ID: 19967917
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Revealing the complexity of chronic obstructive pulmonary disease.
    Vermylen JH, Kalhan R.
    Transl Res; 2013 Oct; 162(4):203-7. PubMed ID: 23932958
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cardiovascular events in patients with chronic obstructive bronchopulmonary disease.
    Giorgini P, Di Giosia P, Ferri L, Ferri C.
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e23-e29. PubMed ID: 27755224
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W.
    Ann Med; 2009 Jan; 41(5):332-43. PubMed ID: 19291518
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Renin turning full circle as cardiovascular risk factor.
    Adiyaman A, Staessen JA.
    Eur Heart J; 2007 Nov; 28(21):2557-8. PubMed ID: 17932427
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical benefit of fibrinogen evaluation.
    Lowe G, Rumley A.
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S87-9. PubMed ID: 10070827
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Uric acid and cardiovascular risk.
    Hebert LA, Rovin B.
    N Engl J Med; 2009 Jan 29; 360(5):540; author reply 540-1. PubMed ID: 19186313
    [No Abstract] [Full Text] [Related]

  • 39. The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.
    Catena C, Cavarape A, Dotto L, Colussi G, Novehllo M, De Marchi S, Sechi LA.
    Adv Clin Path; 2003 Jan 29; 7(1):3-11. PubMed ID: 19774732
    [Abstract] [Full Text] [Related]

  • 40. [Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology].
    Bova AA, Lapitskiĭ DV.
    Klin Med (Mosk); 2009 Jan 29; 87(2):8-13. PubMed ID: 19348292
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.